Related Experiment Video
Updated: Jan 23, 2026

A RAPID Method for Blood Processing to Increase the Yield of Plasma Peptide Levels in Human Blood
Published on: April 28, 2016
Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: A pilot study
Cynthia Marie-Claire1, Cindie Courtin1, Emmanuel Curis2
1INSERM U1144 Optimisation Thérapeutique en Neuropsychopharmacologie, Université Paris Descartes, Université Paris Diderot, Université Sorbonne Paris Cité, Paris, France.
Abstract:
High mobility group box 1 (HMGB1) is a pro-inflammatory cytokine that emerges as a promising peripheral marker of inflammation. HMGB1 and C-reactive protein levels were assessed in plasma of control subjects and remitted patients with bipolar disorder (BD). HMGB1 levels were significantly higher in patients with BD as compared to control subjects whereas C-reactive protein levels did not differ between the two groups. No significant effect of potential covariates was identified. The results of this pilot study suggest that HMGB1 might be a specific peripheral marker of inflammation in BD.
More Related Videos
Related Concept Videos
Bipolar Disorder
Intrinsically Disordered Proteins
Intrinsically Disordered Proteins
Pilot and Numeric Relaying
Protein Buffers in Blood Plasma and Cells
Certain amino acids can exist in a zwitterion state at a...
Drug Distribution: Plasma Protein Binding

